RAF1 and neoplasm: Many resistance mechanisms arising after single RAF or MEK inhibition have been shown to be driven by ERK reactivation, thereby suggesting that concurrent inhibition of the pathway at multiple levels including ERK may induce a more effective tumor growth arrest [22,31].